Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptomatic troponin-I elevations to conduction abnormali...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Nikhil, Khunger, Arjun, Vachhani, Pankit, Colvin, Teresa A., Hattoum, Alexander, Spangenthal, Edward, Curtis, Anne B., Dy, Grace K., Ernstoff, Marc S., Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465686/
https://www.ncbi.nlm.nih.gov/pubmed/31011325
http://dx.doi.org/10.1159/000498985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465686/
https://www.ncbi.nlm.nih.gov/pubmed/31011325
http://dx.doi.org/10.1159/000498985

Ejemplares similares